Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Acylpolyamine Mygalin as a TLR4 Antagonist Based on Molecular Docking and In Vitro Analyses

Full text
Author(s):
Espinoza-Culupu, Abraham [1, 2] ; Vazquez-Ramirez, Ricardo [3] ; Farfan-Lopez, Mariella [4] ; Mendes, Elizabeth [2] ; Notomi Sato, Maria [5] ; da Silva Junior, Pedro Ismael [1, 6] ; Borges, Monamaris Marques [1, 2]
Total Authors: 7
Affiliation:
[1] USP IBu IPT, Interunits Grad Program Biotechnol, BR-01000000 Sao Paulo - Brazil
[2] Butantan Inst, Bacteriol Lab, BR-01000000 Sao Paulo - Brazil
[3] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City 0016, DF - Mexico
[4] Univ Nacl Mayor San Marcos, Microbiol Mol & Biotechnol Lab, Lima Dist 15081 - Peru
[5] Univ Sao Paulo, Sch Med, Lab Dermatol & Immunodeficiencies, BR-01000000 Sao Paulo - Brazil
[6] Butantan Inst, Lab Appl Toxinol LETA, BR-01000000 Sao Paulo - Brazil
Total Affiliations: 6
Document type: Journal article
Source: BIOMOLECULES; v. 10, n. 12 DEC 2020.
Web of Science Citations: 0
Abstract

Toll-like receptors (TLRs) are transmembrane proteins that are key regulators of innate and adaptive immune responses, particularly TLR4, and they have been identified as potential drug targets for the treatment of disease. Several low-molecular-weight compounds are being considered as new drug targets for various applications, including as immune modulators. Mygalin, a 417 Da synthetic bis-acylpolyamine, is an analog of spermidine that has microbicidal activity. In this study, we investigated the effect of mygalin on the innate immune response based on a virtual screening (VS) and molecular docking analysis. Bone marrow-derived macrophages and the cell lines J774A.1 and RAW 264.7 stimulated with lipopolysaccharide (LPS) were used to confirm the data obtained in silico. Virtual screening and molecular docking suggested that mygalin binds to TLR4 via the protein myeloid differentiation factor 2 (MD-2) and LPS. Macrophages stimulated by mygalin plus LPS showed suppressed gene expression of tumor necrosis factor (TNF-alpha), interleukine 6 (IL-6), cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS), as well as inhibition of signaling protein p65 of the nuclear factor kappa B (NF-kappa B), resulting in decreased production of nitric oxide (NO) and TNF-alpha. These results indicate that mygalin has anti-inflammatory potential, being an attractive option to be explored. In addition, we reinforce the importance of virtual screening analysis to assist in the discovery of new drugs. (AU)

FAPESP's process: 13/11212-9 - Mygalin: the immunomodulatory mechanism and potential in the control of bacterial infection
Grantee:Monamaris Marques Borges
Support Opportunities: Regular Research Grants
FAPESP's process: 13/07467-1 - CeTICS - Center of Toxins, Immune-Response and Cell Signaling
Grantee:Hugo Aguirre Armelin
Support Opportunities: Research Grants - Research, Innovation and Dissemination Centers - RIDC